When comparing the genes found to be associated with prostate cancer from the epigenome-wide association study with those from the differential expression analysis, only two genes were found to be significant in both analyses: SHISA3 and LMX1A. Both were slightly underexpressed compared to healthy prostate tissue and contained two CpG sites. This evidence concerns the gene SHISA3 and prostate cancer.